Vaping Is Not Safe: A Case of Acute Eosinophilic Pneumonia following Cannabis Vapor Inhalation

Antwi‐Amoabeng, Daniel; Islam, Raheel

doi:10.1155/2020/9496564

Cited by 9 publications

(7 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, the laboratory-based results of the current investigation showed that salivary immunoinflammatory response is worse in CS and ENDS users than non-smokers. This outcome supports previous studies [ 38 , 39 ] that have shown that vaping is by no means a safe replacement for smoking.…”

Section: Discussionsupporting

confidence: 91%

Comparison of Whole Salivary Cortisol and Interleukin 1-Beta Levels in Light Cigarette-Smokers and Users of Electronic Nicotine Delivery Systems before and after Non-Surgical Periodontal Therapy

Alhumaidan

Al‐Aali

Vohra

et al. 2022

IJERPH

View full text Add to dashboard Cite

There are no studies that have compared whole salivary cortisol (CL) and interleukin 1-beta (IL-1β) levels in cigarette-smokers (CS) and electronic nicotine delivery systems (ENDS)-users before and after non-surgical periodontal therapy (NSPT). The aim was to compare whole salivary CL and IL-1β levels in light CS and ENDS users before and after non-surgical periodontal therapy (NSPT). Self-reported current CS, ENDS users, and non-smokers were included. A questionnaire was used to collect demographic data. All patients underwent NSPT. Periodontal parameters (probing depth (PD], gingival index (GI], clinical attachment loss (AL], plaque index (PI], and marginal bone loss (MBL]) and whole salivary CL and IL-1β were measured at baseline. At 3-months of follow-up, clinical parameters and whole salivary CL and IL-1β were re-assessed. p-values < 1% were arbitrated as statistically significant. Fifty-four individuals (18 CS, 18 ENDS users, and 18 non-smokers) were included. Clinical AL, MT, PD, PI, and MBL were similar in all groups at baseline. At 12-weeks of follow-up, PI (p < 0.01) and PD (p < 0.01) were high in CS and ENDS-users than non-smokers. Among non-smokers, there was a statistically significant correlation between whole salivary cortisol and IL-1β levels at 12-weeks’ follow-up (p < 0.001). There was no difference in whole salivary cortisol and IL-1β levels in CS and ENDS users at baseline and at 12-weeks follow-up. At 12-weeks of follow-up, there was a significant reduction in IL-1β (p < 0.01) and CL (p < 0.01) than baseline. In light CS and ENDS users without periodontal disease, clinical periodontal parameters and whole-salivary CL and Il-1β levels remain unchanged after NSPT.

show abstract

Section: Discussionsupporting

confidence: 91%

Comparison of Whole Salivary Cortisol and Interleukin 1-Beta Levels in Light Cigarette-Smokers and Users of Electronic Nicotine Delivery Systems before and after Non-Surgical Periodontal Therapy

Alhumaidan

Al‐Aali

Vohra

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…In 4 cases vaping precipitated a pneumothorax [52][53][54] and in 2 exacerbated pre-existing asthma [55]. Other diagnoses included eosinophilic pneumonia (n = 4) [56][57][58][59], combination of organizing and lipoid pneumonia (n = 3) [40], hypersensitivity pneumonitis (n = 3) [46,60,61], diffuse alveolar hemorrhage (DAH) (n = 1) [62], acute respiratory distress syndrome (ARDS) (n = 1) [63], a combination of ARDS, organizing pneumonia and diffuse alveolar damage (DAD) (n = 1) [64], epiglottitis (n = 1) [65], and a possible EVALI on asthma grounds (n = 1) [46].…”

Section: Classification Of Casesmentioning

confidence: 99%

A Systematic Literature Review of E-Cigarette-Related Illness and Injury: Not Just for the Respirologist

Tzortzi

Kapetanstrataki

Evangelopoulou

et al. 2020

IJERPH

View full text Add to dashboard Cite

Following the recent electronic cigarette (e-cigarette) illness outbreak, the current review aimed to collect all related clinical cases for study and analysis and provide a critical synopsis of the proposed injury mechanism. Adhering to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) guidelines, e-cigarette-related clinical cases were identified via Google Scholar and PubMed databases. Additionally, references of published case reports and previous review papers were manually searched, revealing 159 publications presenting e-cigarette-related case reports and 19 reports by the Centers for Disease Control and Prevention. 238 individual cases were identified; 53% traumatic injuries due to e-cigarette explosion or self-combustion, 24% respiratory cases, and 12% poisonings. Additional cases pertained to oral, cardiovascular, immunologic, hematologic, allergic reactions, infant complications, and altered medication levels. Case reports were mainly published between 2016–2019 (78%). The oldest case, a lipoid pneumonia, was published in 2012. The current review showed that e-cigarette-related health effects extend beyond the acute lung injury syndrome, including traumatic, thermal injuries and acute intoxications. Physicians should be aware of the distinct clinical presentations and be trained to respond and treat effectively. Regulators and public health authorities should address the regulatory gap regarding electronic nicotine delivery systems (ENDS) and novel tobacco products.

show abstract

“…Another case report of a young person who vaped cannabis oil described symptoms of catatonia, mania, and psychosis supposedly induced by previous cannabis vaping [ 151 ]. Cases of eosinophilic pneumonitis, synthetic cannabinoid intoxication, Torsades de pointes, and cardiac arrest were reported among youth who vaped various forms of marijuana [ 155 , 160 – 162 ]. A qualitative study which interviewed cannabis vaping youth reported participants describing the physical health effects ranging from respiratory, oral, nausea, and appetite related and headaches [ 157 ].…”

Section: Resultsmentioning

confidence: 99%

Cannabis Vaping Among Youth and Young Adults: a Scoping Review

et al. 2022

View full text Add to dashboard Cite

Purpose of Review The purpose of this review was to describe the state-of-the-literature on research specific to cannabis vaping among youth and young adults. Recent Findings Out of 1801 records identified, a total of 202 articles met eligibility criteria for inclusion in this review. Most of this literature (46.0% of studies) was specific to the health effects of cannabis vaping, particularly EVALI (e-cigarette and vaping associated lung injury). Other research areas identified in the review included the etiology (24.3%) and epidemiology (24.8%) of cannabis vaping, in addition to articles on regulation (8.4%) and marketing (5.5%) of the same. Summary Cannabis vaping is increasingly common among youth and young adults and more prevalent is settings where recreational use for adults has been legalized. The literature documents a number of negative health effects of cannabis vaping for young people, along with risk factors and reasons for the same.

show abstract

Vaping Is Not Safe: A Case of Acute Eosinophilic Pneumonia following Cannabis Vapor Inhalation

Cited by 9 publications

References 24 publications

Comparison of Whole Salivary Cortisol and Interleukin 1-Beta Levels in Light Cigarette-Smokers and Users of Electronic Nicotine Delivery Systems before and after Non-Surgical Periodontal Therapy

Comparison of Whole Salivary Cortisol and Interleukin 1-Beta Levels in Light Cigarette-Smokers and Users of Electronic Nicotine Delivery Systems before and after Non-Surgical Periodontal Therapy

A Systematic Literature Review of E-Cigarette-Related Illness and Injury: Not Just for the Respirologist

Cannabis Vaping Among Youth and Young Adults: a Scoping Review

Contact Info

Product

Resources

About